7.130USD+2.30%Mkt Cap: 1.11B $P/E: —1d ago
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access i…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Cheaper
1M Perf
Lower
$31.19BUSDP/E 34.0
$13.85BUSDP/E 91.6
$10.90BUSD
$8.10BUSDP/E 36.2
$6.85BUSD
$5.08BUSD
$4.59BUSDP/E 35.7
$3.43BUSDP/E 159.9
$2.34BUSD
$2.06BUSDP/E 102.8
$1.68BUSD
$1.36BUSD
$1.27BUSD
$1.04BUSDP/E 51.3
$877.77MUSDP/E Infinity
$849.29MUSDP/E 43.4
$756.89MUSDP/E 35.7
$685.69MUSDP/E 69.4
$645.64MUSD
$543.28MUSDP/E 12.8
$565.30MUSD
$533.09MUSD
$516.62MUSD
$507.08MUSDP/E 57.7
$458.45MUSDP/E 26.1
$419.03MUSDP/E 23.5
$393.73MUSDP/E 90.5
$371.17MUSD
$334.10MUSD
$249.14MUSDP/E 15.2
$237.46MUSD
$218.06MUSDP/E 17.7
$169.22MUSD
$151.50MUSDP/E 30.1
$148.04MUSDP/E 39.9
$154.55MUSD
$134.30MUSDP/E Infinity
$119.16MUSDP/E 17.6
$114.15MUSDP/E 25.5
$93.91MUSDP/E 17.0
$90.94MUSD
$65.63MUSDP/E 11.3
$65.05MUSDP/E 23.6
$55.64MUSD
$52.43MUSD
$47.87MUSDP/E 57.6
$45.06MUSDP/E 43.0
$40.30MUSD
$38.36MUSD
$23.19MUSDP/E 55.5
$24.86MUSDP/E 24.0
$23.68MUSD
$19.89MUSD
$13.45MUSD
$13.30MUSD
$12.94MUSD
$11.13MUSD
$9.78MUSDP/E 15.1
$7.61MUSD
$7.54MUSD
$5.90MUSD
$5.49MUSD
$3.76MUSDP/E Infinity
$3.95MUSDP/E 0.0
$3.52MUSD
$3.21MUSD
$2.78MUSD
$2.16MUSDP/E Infinity
$544.4KUSDP/E 0.0
$355.5KUSD
$256.9KUSD
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 31.8
Indicators:|
Key Statistics
Company
Market Cap1.11B $
Enterprise Value1.17B $
Revenue (TTM)419.75M $
Gross Profit257.71M $
Net Income (TTM)-1.59M $
Revenue/Share2.630 USD
Last Price7.130 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.82
PEG—
EV/EBITDA12.49
EV/Revenue2.80
P/S2.43
P/B0.99
EPS (TTM)-0.10
EPS (Forward)0.41
52W Range
4.45028% of range13.88
52W High13.88 USD
52W Low4.450 USD
Profitability
Gross Margin61.53%
Oper. Margin3.80%
EBITDA Margin22.40%
Profit Margin-0.38%
ROE-0.15%
ROA-0.10%
Growth
Revenue Growth0.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF96.33M $
CapEx (TTM)26.56M $
FCF Margin27.77%
FCF Yield10.51%
Net Debt155.15M $
Net Debt/EBITDA1.65
Balance Sheet
Debt/Equity0.29
Current Ratio1.88
Quick Ratio1.78
Book Value/Sh6.633 USD
Cash/Share0.9610 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.480 USD
Upside (mean)+4.9%
Target Range6.000 USD – 10.00 USD
$6.000+4.9% to mean$10.00
# Analysts10
Ownership
Shares Out.155.56M
Float107.28M
Insiders2.57%
Institutions112.58%
Short Interest
Short Ratio7.2d
Short % Float28.41%
Short % Out.18.34%
Shares Short28.53M
Short (prev mo.)25.28M
Technical
SMA 505.612 (+27.1%)
SMA 2008.149 (-12.5%)
Beta1.49
S&P 52W Chg20.05%
Avg Vol (30d)4.20M
Avg Vol (10d)5.82M
Technical Indicators
RSI (14)73.7
MACD0.3452
MACD Signal0.1621
MACD Hist.+0.1830
BB Upper7.067 USD
BB Middle5.774 USD
BB Lower4.482 USD
BB Width44.76%
ATR (14)0.4020 USD
Vol Ratio (20d)1.37x